Genentech USA, Incorporated Contract Details

Defense contract under the Defense Logistics Agency awarded to Genentech USA, Incorporated on 9/15/2016.

Per the U.S. DoD, * Indicates a "small business" classification and ** indicates a "small disadvantaged business". NOTE: the U.S. DoD only publicly reports contracts valued at $6.5 million USD or greater.

The contract language is EXACTLY as it appears on the official U.S. DoD website ( unless otherwise noted.

Contractor: Genentech USA, Incorporated
Department: Defense Logistics Agency
Awarded: 9/15/2016

Genentech USA Inc., South San Francisco, California, has been awarded a $36,344,700 firm-fixed-price requirements contract for Tamiflu. This was a sole-source acquisition using justification 10 U.S. Code 2304 (c) (1). This is a one-year contract with no option periods. Locations of performance are California, North Carolina and Pennsylvania, with a Sept. 14, 2017, performance completion date. Using military services are Army, Navy, Air Force and Marine Corps. Type of appropriation is fiscal 2016 through fiscal 2017 Defense Health Program operations and maintenance funds. The contracting activity is the Defense Logistics Agency Troop Support, Philadelphia, Pennsylvania (SPE2DP-16-D-0008).

Total Contract Value: $36,344,700

View all contracts that include "Genentech USA, Incorporated" in the MiC database.